Published in
Elsevier, Journal of Clinical Virology, (105), p. 112-117, 2018
DOI: 10.1016/j.jcv.2018.06.012
Links
Tools
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA)
Journal article published in 2018 by
S. Rusconi 
,
F. Adorni ,
P. Tau,
V. Borghi,
M. Pecorari,
R. Maserati,
D. Francisci,
L. Monno,
G. Punzi,
P. Meraviglia,
S. Paolucci,
A. Di Biagio,
B. Bruzzone,
A. Mancon,
V. Micheli
and other authors.
,
F. Adorni ,
P. Tau,
V. Borghi,
M. Pecorari,
R. Maserati,
D. Francisci,
L. Monno,
G. Punzi,
P. Meraviglia,
S. Paolucci,
A. Di Biagio,
B. Bruzzone,
A. Mancon,
V. Micheli
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 